Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954248 · ClinicalTrials.gov registry record · NA
Pilot Study for PET/MR Imaging of Covid-19
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04954248: Clinical Trial NA study, sponsored by Stanford University.
NCT04954248 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04954248, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The primary goal of this project is to study the feasibility of a prototype brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of metabolism and perfusion in Covid-19 negative and positive/once positive subjects. This study serves as a pilot study for establishing an imaging protocol for combined PET and MR derived functional information as well as MRI acquired anatomical information.
Interventions
- DIAGNOSTIC_TEST Injected radiotracer with PET Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-09-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04954248
The ClinicalTrials.gov registry entry for NCT04954248 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Injected radiotracer with PET Insert is the first listed.
NCT04954248 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04954248 about?
NCT04954248 is a clinical study titled "Pilot Study for PET/MR Imaging of Covid-19". The primary goal of this project is to study the feasibility of a prototype brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of metabolism and perfusion in Covid-19 negative and positive/once positive subjects. This study serves as a pilot study for establis...
What is the current status of trial NCT04954248?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2022-07-01. Estimated completion is 2023-09-20.
What interventions are being tested in trial NCT04954248?
The interventions under investigation include: Injected radiotracer with PET Insert (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04954248?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.